glutathione pathway to triple negative cancer Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Ferroptosis heterogeneity in triple-negative breast
Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy ScienceDirect Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy Apoptosis and glutathione: beyond an antioxidant Cell Death & Differentiation Glutathione metabolism in cancer progression and treatment resistance PMC Role of Glutathione in Cancer: From Mechanisms to Therapies
Pay in 4 interest-free payments of $5.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5





